Writing for Westlaw Today and Thomson Reuters, Alexander Malyshev and Sarah Ganley of our Cannabis, Hemp & CBD industry group discuss what the cannabis sector can expect as 2025 begins in areas such as federal rescheduling, legislation and litigation.
As we head into 2025, the U.S. cannabis industry stands at a crossroads. Since the beginning of the first Trump administration — which began with the appointment of cannabis opponent Jeff Session as Attorney General — the industry has come a long way. However, despite near universal acceptance of medical marijuana, and growing acceptance of adult-use cannabis at the state level, federal legalization is not here yet. As a result, it makes sense to take a closer look at what the cannabis sector can expect in the years ahead.